MRVI - Maravai Lifesciences Holdings  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRVI is currently covered by 5 analysts with an average price target of $6.39. This is a potential upside of $3.09 (93.64%) from yesterday's end of day stock price of $3.3.

Maravai Lifesciences Holdings 's activity chart (see below) currently has 88 price targets and 59 ratings on display. The stock rating distribution of MRVI is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.87% with an average time for these price targets to be met of 74.75 days.

Highest price target for MRVI is $9, Lowest price target is $2.5, average price target is $5.38.

Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 25-Mar-2025. First documented stock forecast 15-Dec-2020.

Currently out of the existing stock ratings of MRVI, 2 are a HOLD (50%), 2 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

$5

$1.91 (61.81%)

$12

6 months 14 days ago
(25-Mar-2025)

2/7 (28.57%)

$2.7 (117.39%)

105

Buy

$5

$1.91 (61.81%)

$10

6 months 18 days ago
(21-Mar-2025)

4/8 (50%)

$2.73 (120.26%)

115

Hold

$2.5

$-0.59 (-19.09%)

$6

6 months 18 days ago
(21-Mar-2025)

4/7 (57.14%)

$0.23 (10.13%)

58

Buy

$9

$5.91 (191.26%)

$10

11 months 1 days ago
(08-Nov-2024)

3/4 (75%)

$3.92 (77.17%)

37

Hold

$7

$3.91 (126.54%)

$7

1 years 1 days ago
(08-Oct-2024)

7/7 (100%)

$-0.68 (-8.85%)

82

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRVI (Maravai Lifesciences Holdings ) average time for price targets to be met?

On average it took 74.75 days on average for the stock forecasts to be realized with a an average price target met ratio 66.87

Which analyst has the current highest performing score on MRVI (Maravai Lifesciences Holdings ) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings )?

Tejas Savant works at MORGAN STANLEY and has 19 price targets and 11 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings )?

Katie Tryhane with highest potential upside - $50.91

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings )?

John Sourbeer with lowest potential downside - -$0.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?